References
- Akilzhanova A, Nyshanbekkyzy N, Nurkina Z, et al (2013). BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients In Kazakhstan. Central Asian J Global Health, 2, 29.
- Azis F (2009). Gynecological cancer in Indonesia. J Gynecol Oncol, 20, 8-10. https://doi.org/10.3802/jgo.2009.20.1.8
- Assi H, Khoury K, Dbouk H, et al (2013). Epidemiology and prognosis of breast cancer in young women. J Thorac Dis, 5, 2-8
- Beaber E, Buist D, Barlow W, et al (2014). Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res, 74, 4078-89. https://doi.org/10.1158/0008-5472.CAN-13-3400
- Berzina D, Miklasevica M, Jekaterina Z, et al (2013). BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families. BMC Medical Genetics, 14, 61.
- Brown S, Morrison D, Cooke T (2009). Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme. Breast Cancer Res Treat, 116, 603-7. https://doi.org/10.1007/s10549-008-0205-0
- Cecchini R, Constantio J, Culey J, et al (2012). Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention Trials. Cancer Prev Res, 5, 583-92. https://doi.org/10.1158/1940-6207.CAPR-11-0482
- Cherbal F, Salhi N, Bakour R, et al (2012). BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Dis Markers, 32, 343-53. https://doi.org/10.1155/2012/234136
- Dombernowsky S, Weischer M, Freiberg J, et al (2009). Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev, 18, 2339-41. https://doi.org/10.1158/1055-9965.EPI-09-0447
- Evans G, Howell A (2007). Breast cancer risk-assessment models. Breast Cancer Res, 9, 1750.
- Genetics Home Reference. 2013. BRCA1. Accessed December 15, 2013, at http://ghr.nlm.nih.gov/gene/BRCA1.
- Gierisch J, Coeytaux R, Urrutia R, et al (2014). Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev, 22, 1931-43.
- Glass A, Lacey J, Carreon J, et al (2007). Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screeningmammography, and estrogen receptor status. J National Cancer Institute, 99, 1152-61. https://doi.org/10.1093/jnci/djm059
- Haffty B, Choi D, Goyal S, et al (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol, 20, 1653-9. https://doi.org/10.1093/annonc/mdp051
- Hall M, Reid J, Burbidge L, et al (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer, 115, 2222-33. https://doi.org/10.1002/cncr.24200
- Harianto, Mutiara R, Surachmat H (2005). The Risk of The Combination of Oral Contraception with Breast Cancer Incidence of Outpatient Clinic in Cipto Mangunkusumo Hospital. Majalah Ilmu Kefarmasian, 22, 84-99.
- Haryono S, Datasena I, Santosa W, et al (2015). A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia. Asian Pac J Cancer Prev, 16, 2231-5. https://doi.org/10.7314/APJCP.2015.16.6.2231
- Herrick B, Scally M, Madsen A, et al (2006). Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans. Mamm Genome, 17, 257-70. https://doi.org/10.1007/s00335-005-0067-2
- Keshavarzi F, Javadi G, Zeinali S (2012). BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. Familial Cancer, 11, 57-67. https://doi.org/10.1007/s10689-011-9477-3
- Kwong A, On N, Wong C, et al (2012). Identification of BRCA1/2 founder mutations in southern Chinese breast cancer patients using gene sequencing and high resolution dna melting analysis. PLOS One, 7, 43994. https://doi.org/10.1371/journal.pone.0043994
- Kwong A, Shin V, Ho J, et al (2015). Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet, 53, 103132.
- Leong S, Shen Z, Liu T, et al (2010). Is breast cancer the same disease in asian and western countries? World J Surg, 34, 2308-24. https://doi.org/10.1007/s00268-010-0683-1
- Mary B, Jennifer E, Saundra B, et al (2012). NCCN clinical practice guidelines in oncology genetic/familial high-risk assessment: breast and ovarian version I. National Comprehensive Cancer Network.
- Matsuno R, Anderson W, Yamamoto S, et al (2007). Early- and late-onset breast cancer types among women in the united states and Japan. Cancer Epidemiol Bio-markers Prev, 16, 1437-42. https://doi.org/10.1158/1055-9965.EPI-07-0108
- Medimegh I, Troudi W, Stambouli N, et al (2014). Wild-type genotypes of BRCA1 gene SNPs combined with micro RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases occurrence. Med Oncol, 31, 11.
- Mousavi S, Kasaeian A, Mansori K, et al (2013). Addressing the younger age at onset in breast cancer patients in asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. Oncol, 2013, 429862.
- Ng CH, Pathy B, Taib N, et al (2011). Comparison of breast cancer in Indonesia and Malaysia - a clinico-pathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur. Asian Pac J Cancer Prev, 12, 2943-46.
- Nichols H, Trentham A, Egan K, et al (2009). Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev, 18, 1403-9. https://doi.org/10.1158/1055-9965.EPI-08-1094
- Norsa'adah B, Rampal K, Rahman M, et al (2011). Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer, 11, 141. https://doi.org/10.1186/1471-2407-11-141
- Pathy N, Yip C, Taib N, et al (2011). Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast, 20, S75-80.
- Petrucelli N, Daly M, Feldman G (2013). BRCA1 and BRCA2 hereditary breast and ovarian cancer.
- Pilarski R (2009). Cowden syndrome: a critical review of the clinical literature. J Genet Couns, 18, 13-27. https://doi.org/10.1007/s10897-008-9187-7
- Pilato B, Martinucci M, Danza K, et al (2010). Mutations and polymorphic BRCA variants transmission in breast cancer familial members. Breast Cancer Res Treat, 125, 651-7.
- Purnomosari D, Pals G, Wahyono A, et al (2007). BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat, 106, 297-304. https://doi.org/10.1007/s10549-006-9493-4
- Schneider K, Garber J (2010). Li-Fraumeni syndrome. Acessed at November 25, 2014, at http://www.ncbi.nlm.nih.gov/books/NBK1311/.
- Sirait A, Oemiati R, Indrawati L (2009). Hubungan kontrasepsi pil dengan tumor/kanker payudara di Indonesia. Maj Kedokt Indon, 59, 348-56.
- Stahlbom A, Johansson H, Liljegren A, et al (2012). Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer. Familial Cancer, 11, 33-40. https://doi.org/10.1007/s10689-011-9495-1
- Taib N, Yip C, Low W (2011). Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women - The Psycho-socio-cultural Model for breast symptom appraisal: opportunities for intervention. Asian Pacific J Cancer Prev, 12, 1-8.
- UMD-BRCA1 mutations database.. 2015. BRCA1 gene mutation. Accessed April 15, 2015, at http://www.umd.be/BRCA1/
- Wahidin M, Noviani R, Hermawan S, et al (2012). Population-based cancer registry in Indonesia. Asian Pac J Cancer Prev, 13, 1709-10. https://doi.org/10.7314/APJCP.2012.13.4.1709
- Yip C (2009). Breast cancer in Asia. Methods Mol Biol, 471, 51-64. https://doi.org/10.1007/978-1-59745-416-2_3
- Yip C, Cazap E, Anderson B, et al (2010) Breast cancer management in middle-resourcecountries (MRCs): consensus statement from the breast health global initiative. Breast, 20, 12-9.
- Youlden D, Cramb S, Yip C, et al (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11, 101-15.